News

Kaléo Wins Award for Transformative Opioid Countermeasure Device

Kaléo Wins Award for Transformative Opioid Countermeasure Device

Kaléo Honored with First Medical CBRN Defense Consortium Award

Kaléo has recently made a significant mark in drug-delivery technology by receiving the inaugural Prototype Innovation Award from the Medical CBRN Defense Consortium (MCDC). This esteemed recognition was awarded for their exceptional work in developing the Rapid Opioid Countermeasure System (ROCS), also known as Naloxone HCl Injection, USP. The award was presented for the prototype designed to counter ultra-potent weaponized opioids, emphasizing the critical role Kaléo plays in innovative medical solutions.

The Importance of the ROCS

The ROCS is a groundbreaking antidote aimed at addressing the growing threat of potent opioids, which have become a serious concern in both military and civilian contexts. The MCDC has highlighted this initiative as a vital response to urgent public health needs, recognizing that advanced medical countermeasures such as the ROCS are crucial for national security.

Partnership with the Department of Defense

The development of the ROCS was initiated in collaboration with the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical, part of the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND). With funding secured through a prototype contract established in 2019, Kaléo has leveraged this partnership to push the boundaries of countermeasure technology.

Achievements and Recognition

Kaléo CEO Michael Wells expressed gratitude for the recognition, stating that this award bolsters their commitment to advancing medical countermeasures essential for health security. The ROCS project has not only resulted in innovation but also in tangible solutions for treating opioid exposure in various situations. In fact, the auto-injector received U.S. Food and Drug Administration approval in 2022, marking a significant milestone in its journey toward becoming a standard medical tool for first responders.

Production Agreement and Future Prospects

After the successful completion of the prototype phase, a follow-on production agreement was established to manufacture up to 788,000 auto-injectors. This projection indicates a robust response to the pressing need for effective opioid countermeasures in emergency situations. The ROCS is designed for challenging environments, ensuring military personnel and first responders can act swiftly and efficiently in critical moments.

The Role of the ROCS in Military Preparedness

The ROCS not only provides a means to combat opioid exposure among non-opioid-dependent individuals but also reinforces the readiness of military forces. According to Kathy Zolman, Director of the Medical Threat and Countermeasures Division at Advanced Technology International (ATI), the ROCS is a pivotal tool for protecting warfighters against the threat of weaponized opioids.

Acknowledgments and Previous Awards

This award adds to the accolades already amassed by the ROCS program. In 2022, the product team was also honored with the Outstanding Program Management award at the Military Health System Research Symposium (MHSRS), a testament to their diligent management and innovative approaches in medical technology.

Understanding the Rapid Opioid Countermeasure System

Kaléo's ROCS is a user-friendly 10 mg naloxone auto-injector designed for emergency situations involving high-potency opioids. Approved by the FDA, it is aimed at individuals 12 years and older when opioid exposure is suspected. Its design allows for temporary prevention of respiratory depression and central nervous system effects, making it an essential tool in emergency medicine.

Important Safety Information

While the ROCS is a critical resource, it is important to note certain safety considerations. The product is contraindicated for individuals who are hypersensitive to naloxone. Caution must be exercised in opioid-dependent patients, as abrupt withdrawal can occur. Continued monitoring and additional doses of naloxone may be necessary in emergencies.

Frequently Asked Questions

What is the ROCS used for?

The ROCS is used for the emergency treatment of opioid overdose, specifically for individuals suspected of exposure to high-potency opioids.

Who developed the ROCS?

The ROCS was developed by Kaléo, in collaboration with the U.S. Department of Defense.

What recognition has the ROCS received?

The ROCS recently received the inaugural Prototype Innovation Award from the Medical CBRN Defense Consortium for its innovative approach to opioid countermeasures.

When was the ROCS approved?

The ROCS received FDA approval in 2022, marking a significant advancement in opioid emergency treatment.

What safety precautions should be taken with the ROCS?

Patients should be monitored for adverse reactions, and additional doses may be necessary, especially for opioid-dependent individuals to prevent withdrawal symptoms.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 38

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Schloss Johannisberg Leads 2026 Global Vineyard List

Updated Category News Views 179

A 1,200-year-old riesling estate just beat the world at being memorable. Schloss Johannisberg in Germany’s Rheingau has taken No. 1 in The 50 Best Vineyards 2026, moving up from No. 2 last year and also claiming Best Vineyard in Europe. For anyone watching the wine business from the outside, this is not really a story about one bottle edging out another. It is a...

Continue Reading
PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 21

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
SAP Execution Can Steady Operations Beyond Spreadsheets

Updated Category News Views 53

Spreadsheets breed little kingdoms, and SAP is often left outside the gate. That is the operational mess Martin Rowan, managing partner at Reveal USA, Inc. in Naperville, is taking aim at in a Nov. 19, 2026 HelloNation feature. His central point is not terribly glamorous, but it is dead right: a company gets less stable when it uses SAP to explain yesterday's results...

Continue Reading
OFRM Recall Leaves Investors Facing Hard Questions

Updated Category News Views 60

Nothing wrecks a young consumer brand’s glow faster than a recall involving toddlers, and Once Upon A Farm has just learned that lesson in the ugliest possible way. On November 2, 2026, shares of NYSE:OFRM fell 37% to close at $9.44. That left the stock roughly 47% below its $18 IPO price. Those are not the garden-variety bruises of a weak quarter. That is the market...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 156

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Gildan Lawsuit Puts Revenue Controls Under a Harsh Light

Updated Category News Views 61

Receivables have a nasty way of becoming everybody’s problem once the story cracks. Gildan Activewear is staring at that uncomfortable reality after a securities fraud class action was filed on behalf of investors who bought or acquired shares between February 19, 2025 and June 15, 2026. The case, Cortez v. Gildan Activewear Inc., is pending in the U.S. District Court...

Continue Reading
SciBase Sets Its 2027 AGM Nominating Committee Early

Updated Category News Views 80

Four names on a committee roster rarely make anyone pound the table, and they should not. Still, SciBase Holding has put an important bit of corporate housekeeping in place for its 2027 Annual General Meeting: the nominating committee that will handle shareholder-facing governance work ahead of the May 20 meeting in Stockholm. For a small listed medical-technology...

Continue Reading
Zoomlion’s Australian Service Push Looks Built to Last

Updated Category News Views 113

Five Australian business centres are one thing; getting a stalled crane or earthmover moving again is the whole ballgame. Zoomlion’s Nov. 4 customer gathering in Sydney matters because Chairman and CEO Zhan Chunxin kept the discussion on the unglamorous stuff: product quality, technical support, parts availability and local training. That is exactly where an equipment...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 87

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading

Top 5 Most Recently Viewed Articles

Gen Z's Evolving College Search: The Impact of Politics

Updated Category News Views 205

Understanding Gen Z's College Decisions In recent times, higher education choices have become a significant reflection of societal shifts, especially concerning political climates. A new report from an education company highlights how politics influence college decisions among Gen Z students. This demographic, characterized as more conscious of political environments,...

Continue Reading
LiveWire and KYMCO Unveil Electric Maxi-Scooter Plans

Updated Category News Views 46

LiveWire and KYMCO Strengthen Partnership LiveWire, a prominent figure in the electric motorcycle industry, has exciting news to share. In collaboration with KYMCO, a highly regarded powersports manufacturer, the two companies are working to amplify their strategic alliance. This partnership focuses on introducing an electric maxi-scooter tailored specifically for the...

Continue Reading
Rudholm Group's Compliance Portal: Regulatory Game Changer or Just Noise?

Updated Category News Views 180

Rudholm Group just unveiled its new Compliance Portal on February 18, 2026, aiming to tackle the labyrinth of ever-evolving regulations in the apparel sector. You know how it is—every corner of this industry is drowning in red tape, and brands are gasping for air trying to keep up with local laws that change faster than a fashion trend. The CEO, Dennis Lau, stated they...

Continue Reading
Teva's Upcoming Conference Call for Q4 Financial Results

Updated Category News Views 74

Teva's Upcoming Conference Call for Q4 Financial Results TEL AVIV, Israel — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has announced an important event for investors and stakeholders. The company plans to release its fourth quarter 2025 financial results on a specific date. Following the release, Teva will host a conference call and a live webcast to...

Continue Reading
Understanding the Recent Decline of Moderna's Stock and Future Prospects

Updated Category News Views 178

Moderna's Stock Takes a Dive: Key Factors Explained Moderna Inc (NASDAQ: MRNA) has faced a significant drop in its stock value recently, prompting investors to seek clarity on the reasons behind this decline. The company has been in the news with some critical developments that have overshadowed its achievements in the medical field. Recent Clinical Setbacks The primary...

Continue Reading